Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.

Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.

Vasoactive intestinal peptide (VIP) is an anti-inflammatory immunomodulatory neuropeptide with therapeutic potential demonstrated for collagen-induced arthritis. The aim of this study was to characterise its potential anti-arthritic effect on human monocytes, macrophages, T cells, and rheumatoid art...

Detaylı Bibliyografya
Asıl Yazarlar:	Foey, A, Field, S, Ahmed, S, Jain, A, Feldmann, M, Brennan, F, Williams, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BioMed Central 2003

Benzer Materyaller

The role of TNF alpha and IL-1 in rheumatoid arthritis.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

TNF alpha--a pivotal role in rheumatoid arthritis?
Yazar:: Brennan, F, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

TNF alpha as a therapeutic target in rheumatoid arthritis.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

CD40 ligation induces macrophage IL-10 and TNF-alpha production: differential use of the PI3K and p42/44 MAPK-pathways.
Yazar:: Foey, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.
Yazar:: Foey, A, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
Yazar:: Brennan, F, ve diğerleri
Baskı/Yayın Bilgisi: (1989)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
Yazar:: Feldmann, M
Baskı/Yayın Bilgisi: (1996)

Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis.
Yazar:: Foey, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

TNFα - A pivotal role in rheumatoid arthritis?
Yazar:: Brennan, F, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
Yazar:: Elliott, M, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
Yazar:: Williams, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Impact of cAMP on the T-cell response to type II collagen.
Yazar:: Ozegbe, P, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Development of anti-TNF therapy for rheumatoid arthritis.
Yazar:: Feldmann, M
Baskı/Yayın Bilgisi: (2002)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
Yazar:: Taylor, P, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha.
Yazar:: Parry, S, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

The importance of T cell interactions with macrophages in rheumatoid cytokine production.
Yazar:: Brennan, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF&alpha; blocker failure
Yazar:: Kekow J, ve diğerleri
Baskı/Yayın Bilgisi: (2012-07-01)

Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNF&alpha; therapy
Yazar:: Hubert Marotte, ve diğerleri
Baskı/Yayın Bilgisi: (2008-08-01)

Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
Yazar:: Andersson, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
Yazar:: Brennan, F, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Cytokine expression in rheumatoid arthritis.
Yazar:: Brennan, F, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis.
Yazar:: Campbell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Rheumatoid arthritis.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
Yazar:: Taylor, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-&alpha; therapy for rheumatoid arthritis
Yazar:: Shu Kachi, ve diğerleri
Baskı/Yayın Bilgisi: (2010-06-01)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1997)